Information on stock, financials, earnings, subsidiaries, investors, and executives for 10x Genomics. Use the PitchBook Platform to explore the full profile. According to analysts' consensus price target of $74.17, 10x Genomics has a potential upside of 21.9% from its current price of $60.85. Amount of Analyst� 10x Genomics, Inc. Class A Common Stock (TXG) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Prev Close 62.27, 52 Wk Low 45.11. Open 62.96, 52 Wk High 108.36. Day Low 61.14, Volume 214,127.00. Day High 63.05, Avg 10D Vol 421,011.00�
In depth view into TXG (10x Genomics) stock including the latest price, news, dividend history, earnings information and financials.
View the latest 10x Genomics Inc. (TXG) stock price, news, historical charts, analyst ratings and financial information from WSJ. IPO & Stock Price. 10X Genomics is registered under the ticker NASDAQ:TXG . Their stock opened with $39.00 in its Sep 11, 2019 IPO. Stock Symbol� We are offering shares of our Class A common stock to be sold in the offering. The initial public offering price is� 10x Genomics stock quote and TXG charts. Latest stock price today and the US's most active stock market forums. 13 Sep 2019 Shares of 10X Genomics surged more than 35% on its first day of trading to close at $52.75, well above its $39 initial price offering starting point. In its debut, 10x offered 10 million shares of Class A common stock, as well as� 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North � 3 Dec 2019 While the stock saw some volatility post its debut, it currently trades at about $65, a ~65% increase from its IPO price of $39 per share.
IPO & Stock Price. 10X Genomics is registered under the ticker NASDAQ:TXG . Their stock opened with $39.00 in its Sep 11, 2019 IPO. Stock Symbol�
PLEASANTON, Calif., Feb. 25, 2020 -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming 40th Annual Cowen� TXG | Complete 10x Genomics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. 26 Sep 2019 Investors should pass on this stock. If investors ignore the patent infringement lawsuits brought by Bio-Rad, then 10X Genomics has a lot to offer�
10X Genomics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.
View 10x Genomics Inc. TXG investment & stock information. Get the latest 10x Genomics Inc. TXG detailed stock quotes, stock data, Real-Time ECN, charts,� Learn about TXG with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar � View the latest 10x Genomics Inc. (TXG) stock price, news, historical charts, analyst ratings and financial information from WSJ. IPO & Stock Price. 10X Genomics is registered under the ticker NASDAQ:TXG . Their stock opened with $39.00 in its Sep 11, 2019 IPO. Stock Symbol� We are offering shares of our Class A common stock to be sold in the offering. The initial public offering price is� 10x Genomics stock quote and TXG charts. Latest stock price today and the US's most active stock market forums. 13 Sep 2019 Shares of 10X Genomics surged more than 35% on its first day of trading to close at $52.75, well above its $39 initial price offering starting point. In its debut, 10x offered 10 million shares of Class A common stock, as well as�
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North �
10x Genomics is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in� In depth view into TXG (10x Genomics) stock including the latest price, news, dividend history, earnings information and financials. 13 Sep 2019 In its first day of trading, 10x Genomics' initial share price of $39 jumped as high as 48% to $57.80 before settling at $52.75 by the close and�